Related Experiment Video
Updated: Feb 19, 2026
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
9.2K
Comparative Study of Toxicity of Alkoxyamines In Vitro and In Vivo
N A Popova1, G M Sysoeva2, V P Nikolin3
1Federal Research Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia. pathol@inbox.ru.
Bulletin of Experimental Biology and Medicine
|November 10, 2017
Summary
Alkoxyamines show a dose-dependent toxic effect on breast tumor cells in vitro. In vivo, they inhibited tumor growth and enhanced normal macrophage activity, suggesting potential theranostic applications.
Area of Science:
- Biochemistry
- Oncology
- Immunology
Background:
- Alkoxyamines are chemical compounds with potential biological activity.
- Understanding their effects on both cancerous and normal cells is crucial for therapeutic development.
Purpose of the Study:
- To investigate the in vitro and in vivo effects of alkoxyamines on normal and tumor cells.
- To evaluate the potential of alkoxyamines as theranostic agents.
Main Methods:
- In vitro studies using human breast tumor MCF7 cell line.
- In vivo studies involving transplantation of Krebs-2 ascites carcinoma cells in mice.
- Assessment of peritoneal macrophage functional activity.
Main Results:
- Alkoxyamines exhibited a dose-dependent toxicity against MCF7 breast tumor cells.
- Preincubation of Krebs-2 ascites carcinoma cells with alkoxyamines prevented tumor growth in mice.
- Alkoxyamines demonstrated an increase in the functional activity of normal mouse peritoneal macrophages.
Conclusions:
- Alkoxyamines possess selective toxicity towards tumor cells while stimulating normal immune cells.
- These findings support the investigation of alkoxyamines as potential theranostic agents for cancer treatment.
Related Concept Videos
01:23Toxicity Testing in Animals
25
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
25
01:17Equivalence: In Vitro and In Vivo Bioequivalence
259
Body:Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts.
259
01:16Methods for Studying Drug Absorption: In vitro
649
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
649
01:25Mutagenicity and Carcinogenicity
2.0K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
01:20Drug Product Performance: In Vitro–In Vivo Correlation
292
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
292
01:21Toxicokinetics: Overview
25
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
25